Leukemia Cancer Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: LF77D9E37071EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Leukemia Cancer in Global, including the following market information:

Global Leukemia Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Leukemia Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Leukemia Cancer include Biogen, GSK, Novartis, Pfizer, Roche, Takeda Oncology, Teva Pharmaceutical, Celgene and Daiichi Sankyo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leukemia Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Leukemia Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Leukemia Cancer Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Biological Therapy
• Stem Cell Transplant

Global Leukemia Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Leukemia Cancer Market Segment Percentages, by Application, 2021 (%)

• Acute Myeloid Leukaemia (AML)
• Chronic Myeloid Leukaemia (CML)
• Acute Lymphoblastic Leukaemia (ALL)
• Chronic Lymphocytic Leukaemia (CLL)

Global Leukemia Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Leukemia Cancer Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Leukemia Cancer revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Leukemia Cancer revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biogen
• GSK
• Novartis
• Pfizer
• Roche
• Takeda Oncology
• Teva Pharmaceutical
• Celgene
• Daiichi Sankyo
• EISAI
• Sunesis Pharmaceuticals
• Bristol-Myers Squibb
• Spectrum Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Leukemia Cancer Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Leukemia Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LEUKEMIA CANCER OVERALL MARKET SIZE

2.1 Global Leukemia Cancer Market Size: 2021 VS 2028
2.2 Global Leukemia Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Leukemia Cancer Players in Global Market
3.2 Top Global Leukemia Cancer Companies Ranked by Revenue
3.3 Global Leukemia Cancer Revenue by Companies
3.4 Top 3 and Top 5 Leukemia Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Leukemia Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Leukemia Cancer Players in Global Market
  3.6.1 List of Global Tier 1 Leukemia Cancer Companies
  3.6.2 List of Global Tier 2 and Tier 3 Leukemia Cancer Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Leukemia Cancer Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Radiation Therapy
  4.1.4 Targeted Therapy
  4.1.5 Biological Therapy
  4.1.6 Stem Cell Transplant
4.2 By Type - Global Leukemia Cancer Revenue & Forecasts
  4.2.1 By Type - Global Leukemia Cancer Revenue, 2017-2022
  4.2.2 By Type - Global Leukemia Cancer Revenue, 2023-2028
  4.2.3 By Type - Global Leukemia Cancer Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Leukemia Cancer Market Size, 2021 & 2028
  5.1.2 Acute Myeloid Leukaemia (AML)
  5.1.3 Chronic Myeloid Leukaemia (CML)
  5.1.4 Acute Lymphoblastic Leukaemia (ALL)
  5.1.5 Chronic Lymphocytic Leukaemia (CLL)
5.2 By Application - Global Leukemia Cancer Revenue & Forecasts
  5.2.1 By Application - Global Leukemia Cancer Revenue, 2017-2022
  5.2.2 By Application - Global Leukemia Cancer Revenue, 2023-2028
  5.2.3 By Application - Global Leukemia Cancer Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Leukemia Cancer Market Size, 2021 & 2028
6.2 By Region - Global Leukemia Cancer Revenue & Forecasts
  6.2.1 By Region - Global Leukemia Cancer Revenue, 2017-2022
  6.2.2 By Region - Global Leukemia Cancer Revenue, 2023-2028
  6.2.3 By Region - Global Leukemia Cancer Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Leukemia Cancer Revenue, 2017-2028
  6.3.2 US Leukemia Cancer Market Size, 2017-2028
  6.3.3 Canada Leukemia Cancer Market Size, 2017-2028
  6.3.4 Mexico Leukemia Cancer Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Leukemia Cancer Revenue, 2017-2028
  6.4.2 Germany Leukemia Cancer Market Size, 2017-2028
  6.4.3 France Leukemia Cancer Market Size, 2017-2028
  6.4.4 U.K. Leukemia Cancer Market Size, 2017-2028
  6.4.5 Italy Leukemia Cancer Market Size, 2017-2028
  6.4.6 Russia Leukemia Cancer Market Size, 2017-2028
  6.4.7 Nordic Countries Leukemia Cancer Market Size, 2017-2028
  6.4.8 Benelux Leukemia Cancer Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Leukemia Cancer Revenue, 2017-2028
  6.5.2 China Leukemia Cancer Market Size, 2017-2028
  6.5.3 Japan Leukemia Cancer Market Size, 2017-2028
  6.5.4 South Korea Leukemia Cancer Market Size, 2017-2028
  6.5.5 Southeast Asia Leukemia Cancer Market Size, 2017-2028
  6.5.6 India Leukemia Cancer Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Leukemia Cancer Revenue, 2017-2028
  6.6.2 Brazil Leukemia Cancer Market Size, 2017-2028
  6.6.3 Argentina Leukemia Cancer Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Leukemia Cancer Revenue, 2017-2028
  6.7.2 Turkey Leukemia Cancer Market Size, 2017-2028
  6.7.3 Israel Leukemia Cancer Market Size, 2017-2028
  6.7.4 Saudi Arabia Leukemia Cancer Market Size, 2017-2028
  6.7.5 UAE Leukemia Cancer Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biogen
  7.1.1 Biogen Corporate Summary
  7.1.2 Biogen Business Overview
  7.1.3 Biogen Leukemia Cancer Major Product Offerings
  7.1.4 Biogen Leukemia Cancer Revenue in Global Market (2017-2022)
  7.1.5 Biogen Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Leukemia Cancer Major Product Offerings
  7.2.4 GSK Leukemia Cancer Revenue in Global Market (2017-2022)
  7.2.5 GSK Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Leukemia Cancer Major Product Offerings
  7.3.4 Novartis Leukemia Cancer Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Leukemia Cancer Major Product Offerings
  7.4.4 Pfizer Leukemia Cancer Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Leukemia Cancer Major Product Offerings
  7.5.4 Roche Leukemia Cancer Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 Takeda Oncology
  7.6.1 Takeda Oncology Corporate Summary
  7.6.2 Takeda Oncology Business Overview
  7.6.3 Takeda Oncology Leukemia Cancer Major Product Offerings
  7.6.4 Takeda Oncology Leukemia Cancer Revenue in Global Market (2017-2022)
  7.6.5 Takeda Oncology Key News
7.7 Teva Pharmaceutical
  7.7.1 Teva Pharmaceutical Corporate Summary
  7.7.2 Teva Pharmaceutical Business Overview
  7.7.3 Teva Pharmaceutical Leukemia Cancer Major Product Offerings
  7.7.4 Teva Pharmaceutical Leukemia Cancer Revenue in Global Market (2017-2022)
  7.7.5 Teva Pharmaceutical Key News
7.8 Celgene
  7.8.1 Celgene Corporate Summary
  7.8.2 Celgene Business Overview
  7.8.3 Celgene Leukemia Cancer Major Product Offerings
  7.8.4 Celgene Leukemia Cancer Revenue in Global Market (2017-2022)
  7.8.5 Celgene Key News
7.9 Daiichi Sankyo
  7.9.1 Daiichi Sankyo Corporate Summary
  7.9.2 Daiichi Sankyo Business Overview
  7.9.3 Daiichi Sankyo Leukemia Cancer Major Product Offerings
  7.9.4 Daiichi Sankyo Leukemia Cancer Revenue in Global Market (2017-2022)
  7.9.5 Daiichi Sankyo Key News
7.10 EISAI
  7.10.1 EISAI Corporate Summary
  7.10.2 EISAI Business Overview
  7.10.3 EISAI Leukemia Cancer Major Product Offerings
  7.10.4 EISAI Leukemia Cancer Revenue in Global Market (2017-2022)
  7.10.5 EISAI Key News
7.11 Sunesis Pharmaceuticals
  7.11.1 Sunesis Pharmaceuticals Corporate Summary
  7.11.2 Sunesis Pharmaceuticals Business Overview
  7.11.3 Sunesis Pharmaceuticals Leukemia Cancer Major Product Offerings
  7.11.4 Sunesis Pharmaceuticals Leukemia Cancer Revenue in Global Market (2017-2022)
  7.11.5 Sunesis Pharmaceuticals Key News
7.12 Bristol-Myers Squibb
  7.12.1 Bristol-Myers Squibb Corporate Summary
  7.12.2 Bristol-Myers Squibb Business Overview
  7.12.3 Bristol-Myers Squibb Leukemia Cancer Major Product Offerings
  7.12.4 Bristol-Myers Squibb Leukemia Cancer Revenue in Global Market (2017-2022)
  7.12.5 Bristol-Myers Squibb Key News
7.13 Spectrum Pharmaceuticals
  7.13.1 Spectrum Pharmaceuticals Corporate Summary
  7.13.2 Spectrum Pharmaceuticals Business Overview
  7.13.3 Spectrum Pharmaceuticals Leukemia Cancer Major Product Offerings
  7.13.4 Spectrum Pharmaceuticals Leukemia Cancer Revenue in Global Market (2017-2022)
  7.13.5 Spectrum Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Leukemia Cancer Market Opportunities & Trends in Global Market
Table 2. Leukemia Cancer Market Drivers in Global Market
Table 3. Leukemia Cancer Market Restraints in Global Market
Table 4. Key Players of Leukemia Cancer in Global Market
Table 5. Top Leukemia Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Leukemia Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Leukemia Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Leukemia Cancer Product Type
Table 9. List of Global Tier 1 Leukemia Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Leukemia Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Leukemia Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Leukemia Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Leukemia Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Leukemia Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Leukemia Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Leukemia Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Leukemia Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Leukemia Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Leukemia Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Leukemia Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Leukemia Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Leukemia Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Leukemia Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Leukemia Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Leukemia Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Leukemia Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Leukemia Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Leukemia Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Leukemia Cancer Revenue, (US$, Mn), 2023-2028
Table 30. Biogen Corporate Summary
Table 31. Biogen Leukemia Cancer Product Offerings
Table 32. Biogen Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Leukemia Cancer Product Offerings
Table 35. GSK Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Leukemia Cancer Product Offerings
Table 38. Novartis Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Leukemia Cancer Product Offerings
Table 41. Pfizer Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Leukemia Cancer Product Offerings
Table 44. Roche Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 45. Takeda Oncology Corporate Summary
Table 46. Takeda Oncology Leukemia Cancer Product Offerings
Table 47. Takeda Oncology Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceutical Corporate Summary
Table 49. Teva Pharmaceutical Leukemia Cancer Product Offerings
Table 50. Teva Pharmaceutical Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 51. Celgene Corporate Summary
Table 52. Celgene Leukemia Cancer Product Offerings
Table 53. Celgene Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 54. Daiichi Sankyo Corporate Summary
Table 55. Daiichi Sankyo Leukemia Cancer Product Offerings
Table 56. Daiichi Sankyo Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 57. EISAI Corporate Summary
Table 58. EISAI Leukemia Cancer Product Offerings
Table 59. EISAI Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 60. Sunesis Pharmaceuticals Corporate Summary
Table 61. Sunesis Pharmaceuticals Leukemia Cancer Product Offerings
Table 62. Sunesis Pharmaceuticals Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 63. Bristol-Myers Squibb Corporate Summary
Table 64. Bristol-Myers Squibb Leukemia Cancer Product Offerings
Table 65. Bristol-Myers Squibb Leukemia Cancer Revenue (US$, Mn), (2017-2022)
Table 66. Spectrum Pharmaceuticals Corporate Summary
Table 67. Spectrum Pharmaceuticals Leukemia Cancer Product Offerings
Table 68. Spectrum Pharmaceuticals Leukemia Cancer Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Leukemia Cancer Segment by Type in 2021
Figure 2. Leukemia Cancer Segment by Application in 2021
Figure 3. Global Leukemia Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Leukemia Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Leukemia Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Leukemia Cancer Revenue in 2021
Figure 8. By Type - Global Leukemia Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Leukemia Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Leukemia Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Leukemia Cancer Revenue Market Share, 2017-2028
Figure 12. US Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Leukemia Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Leukemia Cancer Revenue Market Share, 2017-2028
Figure 24. China Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Leukemia Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Leukemia Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Leukemia Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. Biogen Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Takeda Oncology Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceutical Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Celgene Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Daiichi Sankyo Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. EISAI Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sunesis Pharmaceuticals Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bristol-Myers Squibb Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Spectrum Pharmaceuticals Leukemia Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)